{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-033142","form_type":"8-K","ticker":"GERN","cik":"0000886744","company_name":"GERON CORP","filed_at":"2024-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.152089+00:00","generated_at":"2026-06-04T14:22:03.516391+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Geron updates risk factors and corporate presentation; no material new event","bullets":["Updated risk factor disclosure emphasizes sole reliance on imetelstat and risks of clinical trial failures.","Corporate presentation dated March 2024 made available on company website.","No specific new clinical, financial, or regulatory event; risks remain consistent with prior filings."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-033142","json":"https://secwatch.observer/filing/0000950170-24-033142.json","markdown":"https://secwatch.observer/filing/0000950170-24-033142.md","text":"https://secwatch.observer/filing/0000950170-24-033142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/886744/000095017024033142/0000950170-24-033142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/886744/000095017024033142/gern-20240318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T14:22:03.516391+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}